Amy J. Kuntz

960 total citations · 1 hit paper
9 papers, 771 citations indexed

About

Amy J. Kuntz is a scholar working on Psychiatry and Mental health, Pharmacology and Economics and Econometrics. According to data from OpenAlex, Amy J. Kuntz has authored 9 papers receiving a total of 771 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 4 papers in Pharmacology and 2 papers in Economics and Econometrics. Recurrent topics in Amy J. Kuntz's work include Schizophrenia research and treatment (6 papers), Treatment of Major Depression (4 papers) and Electroconvulsive Therapy Studies (2 papers). Amy J. Kuntz is often cited by papers focused on Schizophrenia research and treatment (6 papers), Treatment of Major Depression (4 papers) and Electroconvulsive Therapy Studies (2 papers). Amy J. Kuntz collaborates with scholars based in United States. Amy J. Kuntz's co-authors include Gary D. Tollefson, S.H. Hamilton, Pierre V. Trân, Scott W. Andersen, Charles M. Beasley, Janet H. Potvin, William F. Page, Charles Lawrence, Peter Greenwald and P.V. Tran and has published in prestigious journals such as Cancer, Biological Psychiatry and American Journal of Public Health.

In The Last Decade

Amy J. Kuntz

9 papers receiving 724 citations

Hit Papers

Double-Blind Comparison of Olanzapine Versus Risperidone ... 1997 2026 2006 2016 1997 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy J. Kuntz United States 6 580 157 134 129 84 9 771
Jonathan Thomas United States 10 551 0.9× 84 0.5× 209 1.6× 140 1.1× 113 1.3× 25 820
Hiram Joseph Wildgust United Kingdom 13 436 0.8× 85 0.5× 56 0.4× 91 0.7× 37 0.4× 18 734
Anna‐Greta Nylander Denmark 17 374 0.6× 55 0.4× 106 0.8× 92 0.7× 38 0.5× 33 905
Richard Hodgson United Kingdom 16 460 0.8× 28 0.2× 102 0.8× 201 1.6× 44 0.5× 36 757
Hui Wu China 17 382 0.7× 83 0.5× 68 0.5× 151 1.2× 24 0.3× 51 868
Maila Majak Sweden 6 581 1.0× 77 0.5× 172 1.3× 176 1.4× 42 0.5× 8 734
Pia Vattulainen Finland 14 542 0.9× 105 0.7× 86 0.6× 112 0.9× 27 0.3× 27 1.0k
M. Bouhassira France 13 262 0.5× 148 0.9× 47 0.4× 94 0.7× 35 0.4× 25 532
A. Torbeyns United States 9 551 0.9× 90 0.6× 78 0.6× 89 0.7× 42 0.5× 14 677
Ben Lyons United States 7 619 1.1× 59 0.4× 24 0.2× 309 2.4× 60 0.7× 8 908

Countries citing papers authored by Amy J. Kuntz

Since Specialization
Citations

This map shows the geographic impact of Amy J. Kuntz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy J. Kuntz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy J. Kuntz more than expected).

Fields of papers citing papers by Amy J. Kuntz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy J. Kuntz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy J. Kuntz. The network helps show where Amy J. Kuntz may publish in the future.

Co-authorship network of co-authors of Amy J. Kuntz

This figure shows the co-authorship network connecting the top 25 collaborators of Amy J. Kuntz. A scholar is included among the top collaborators of Amy J. Kuntz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy J. Kuntz. Amy J. Kuntz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Tollefson, Gary D. & Amy J. Kuntz. (1999). Review of recent clinical studies with olanzapine. The British Journal of Psychiatry. 174(S37). 30–35. 42 indexed citations
2.
Tran, P.V., G.D. Tollefson, Scott W. Andersen, Amy J. Kuntz, & S.H. Hamilton. (1998). Olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. Schizophrenia Research. 29(1-2). 205–205. 10 indexed citations
3.
Trân, Pierre V., S.H. Hamilton, Amy J. Kuntz, et al.. (1997). Double-Blind Comparison of Olanzapine Versus Risperidone in the Treatment of Schizophrenia and Other Psychotic Disorders. Journal of Clinical Psychopharmacology. 17(5). 407–418. 567 indexed citations breakdown →
4.
Tran, P.V., G.D. Tollefson, S.H. Hamilton, & Amy J. Kuntz. (1997). Olanzapine vs. risperidone in the treatment of psychosis. Biological Psychiatry. 42(1). 178S–179S. 5 indexed citations
5.
Tollefson, Gary D., Pierre V. Trân, S.H. Hamilton, & Amy J. Kuntz. (1997). Olanzapine versus risperidone in the treatment of psychosis. Preliminary report. Schizophrenia Research. 24(1-2). 191–192. 15 indexed citations
6.
Tran, P.V., G.D. Tollefson, Scott W. Andersen, Amy J. Kuntz, & S.H. Hamilton. (1997). P.2.062 Olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. European Neuropsychopharmacology. 7. S212–S213. 2 indexed citations
7.
Beasley, Charles M., et al.. (1996). Olanzaplne versus placebo, results of the United-States double-blind olanzapine trial. European Neuropsychopharmacology. 6. 58–58. 4 indexed citations
8.
Lawrence, Charles, et al.. (1985). Mortality patterns of New York State Vietnam Veterans.. American Journal of Public Health. 75(3). 277–279. 47 indexed citations
9.
Page, William F. & Amy J. Kuntz. (1980). Racial and socioeconomic factors in cancer survival. A comparison of veterans administration results with selected studies. Cancer. 45(5). 1029–1040. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026